Galza Tablet 50mg is primarily indicated in conditions like Type Il diabetes mellitus.
Galza Tablet 50mg produces potentially life-threatening effects which include Angioedema. which are responsible for the discontinuation of Galza Tablet 50mg therapy., The signs and symptoms that are produced after the acute overdosage of Galza Tablet 50mg include Muscle aches, Fever, Swelling of feet and lower legs, Mild paresthesia., The symptomatic adverse reactions produced by Galza Tablet 50mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, Asthenia, Hypoglycemia.
Galza Tablet 50mg is contraindicated in conditions like Hypersensitivity to the drug.
Do not use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. not recommended in ESRD on haemodialysis patients. Do not use in patients with hepatic impairment, including patients with pre-treatment ALT or AST > 3x ULN. Liver function should be monitored during treatment with Galza Tablet 50mg at three-month intervals during the first year and periodically thereafter. Patients who develop jaundice or other signs suggestive of liver dysfunction should discontinue it. Following withdrawal of treatment with Galza Tablet 50mg and LFT normalisation, treatment with Galza Tablet 50mg should not be reinitiated. Monitoring for skin disorders, such as blistering or ulceration, is recommended while keeping with routine care of the diabetic patient.